Related references
Note: Only part of the references are listed.Association Between Supratotal Glioblastoma Resection and Patient Survival: A Systematic Review and Meta-Analysis
Fatih Incekara et al.
WORLD NEUROSURGERY (2019)
Supratotal resection in glioma: a systematic review
Charles N. de Leeuw et al.
NEURO-ONCOLOGY (2019)
The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
Maryam Moradi Binabaj et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
An Examination of the Role of Supramaximal Resection of Temporal Lobe Glioblastoma Multiforme
Chad A. Glenn et al.
WORLD NEUROSURGERY (2018)
Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes
David Mampre et al.
BRITISH JOURNAL OF NEUROSURGERY (2018)
Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival
Rachel Grossman et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis
Paolo Perrini et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience
Federico Pessina et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma
Maryam Rahman et al.
JOURNAL OF NEUROSURGERY (2017)
The Survival Advantage of Supratotal Resection of Glioblastoma Using Selective Cortical Mapping and the Subpial Technique
Yoshua Esquenazi et al.
NEUROSURGERY (2017)
Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma
Spyros Darmanis et al.
CELL REPORTS (2017)
Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology
Oliver Eidel et al.
PLOS ONE (2017)
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Yan Michael Li et al.
JOURNAL OF NEUROSURGERY (2016)
Isocitrate Dehydrogenase (IDH) 1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
Jun-Rui Chen et al.
MEDICINE (2016)
Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma
Ilker Y. Eyuepoglu et al.
ONCOTARGET (2016)
Association of the Extent of Resection With Survival in Glioblastoma A Systematic Review and Meta-analysis
Timothy J. Brown et al.
JAMA ONCOLOGY (2016)
New Biomolecular Approaches to the Treatment of Glioblastoma Multiforme
I. S. Bryukhovetskii et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
Pei Yang et al.
ONCOTARGET (2015)
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma
Matthew M. Grabowski et al.
JOURNAL OF NEUROSURGERY (2014)
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
Jason Beiko et al.
NEURO-ONCOLOGY (2014)
Patient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of Gliomas
Anne L. Baldock et al.
PLOS ONE (2014)
Recovering the raw data behind a non-parametric survival curve
Zhihui Liu et al.
SYSTEMATIC REVIEWS (2014)
The influence of surgery on recurrence pattern of glioblastoma
Pasquale De Bonis et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2013)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Surgical resection of malignant gliomas-role in optimizing patient outcome
Ilker Y. Eyuepoglu et al.
NATURE REVIEWS NEUROLOGY (2013)
Prognostic Value of Residual Fluorescent Tissue in Glioblastoma Patients After Gross Total Resection in 5-Aminolevulinic Acid-Guided Surgery
Guillermo Aldave et al.
NEUROSURGERY (2013)
IDH1/IDH2 Mutations Define the Prognosis and Molecular Profiles of Patients with Gliomas: A Meta-Analysis
Peng Zou et al.
PLOS ONE (2013)
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
Patricia Guyot et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
An extent of resection threshold for newly diagnosed glioblastomas
Nader Sanai et al.
JOURNAL OF NEUROSURGERY (2011)
ASSOCIATION OF SURGICALLY ACQUIRED MOTOR AND LANGUAGE DEFICITS ON OVERALL SURVIVAL AFTER RESECTION OF GLIOBLASTOMA MULTIFORME
Matthew J. McGirt et al.
NEUROSURGERY (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
M Lacroix et al.
JOURNAL OF NEUROSURGERY (2001)
Share Paper
